Literature DB >> 9531008

Molecular aspects of poliovirus biology with a special focus on the interactions with nerve cells.

B Blondel1, G Duncan, T Couderc, F Delpeyroux, N Pavio, F Colbère-Garapin.   

Abstract

Poliovirus (PV), the pathogenic agent of paralytic poliomyelitis, is the prototype of the picornavirus family. Although paralytic poliomyelitis has been nearly totally eradicated in most industrialized countries, PV continues to be an important public health problem in many developing countries. Moreover, in industrialized countries, two current concerns are the occurrence, albeit at a very low frequency, of vaccine-associated paralytic poliomyelitis, due to the genetic instability of the attenuated oral PV strains in vaccines, and the emergence of a neuro-muscular pathology in many survivors of the acute disease, called the post-polio syndrome. PV has been targeted by the World Health Organization for world-wide eradication in the coming decade and continues to be the subject of intensive research. The advances made in the molecular biology of PV, taken together with the development of new animal and cell models, have permitted a new look at a key step in the pathogenesis of poliomyelitis, i.e. the interactions between PV and nerve cells. These aspects of PV biology are developed in this review according to three themes: (i) the PV host range; (ii) the molecular determinants of PV neurovirulence and attenuation; and (iii) the persistence of PV in nerve cells, which has proven to be an interesting new domain in the field of PV research.

Entities:  

Mesh:

Year:  1998        PMID: 9531008     DOI: 10.3109/13550289809113478

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  9 in total

Review 1.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

2.  Poliovirus-induced apoptosis is reduced in cells expressing a mutant CD155 selected during persistent poliovirus infection in neuroblastoma cells.

Authors:  Anne-Sophie Gosselin; Yannick Simonin; Florence Guivel-Benhassine; Vincent Rincheval; Jean-Luc Vayssière; Bernard Mignotte; Florence Colbère-Garapin; Thérèse Couderc; Bruno Blondel
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccinees.

Authors:  N S Cuervo; S Guillot; N Romanenkova; M Combiescu; A Aubert-Combiescu; M Seghier; V Caro; R Crainic; F Delpeyroux
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Genomic analysis of recombinant sabin clinical isolates.

Authors:  Eleni Paximadi; Ioannis Karakasiliotis; Zissis Mamuris; Constantinos Stathopoulos; Vassilis Krikelis; Panayotis Markoulatos
Journal:  Virus Genes       Date:  2006-04       Impact factor: 2.332

5.  Poliovirus type 1 infection of murine PRNP-knockout neuronal cells.

Authors:  Andreina Baj; Alessia Bettaccini; Takuya Nishimura; Takashi Onodera; Antonio Toniolo
Journal:  J Neurovirol       Date:  2005-07       Impact factor: 2.643

6.  Poliovirus internal ribosome entry segment structure alterations that specifically affect function in neuronal cells: molecular genetic analysis.

Authors:  Cécile E Malnou; Tuija A A Pöyry; Richard J Jackson; Katherine M Kean
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

7.  Receptor modification as a therapeutic approach against viral diseases.

Authors:  Rabia Farid; Mohammad Haroon Khan; Hamid Rashid
Journal:  Bioinformation       Date:  2012-04-13

8.  Genetic relationships and epidemiological links between wild type 1 poliovirus isolates in Pakistan and Afghanistan.

Authors:  Mehar Angez; Shahzad Shaukat; Muhammad M Alam; Salmaan Sharif; Adnan Khurshid; Syed Sohail Zahoor Zaidi
Journal:  Virol J       Date:  2012-02-22       Impact factor: 4.099

9.  S2M: A Stochastic Simulation Model of Poliovirus Genetic State Transition.

Authors:  Carol L Ecale Zhou
Journal:  Bioinform Biol Insights       Date:  2016-06-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.